The Osteosarcoma Institute is now accepting Letters of Intent (LOI) for the 2023-2024 Grant Cycle for Clinical Trials, Correlative Science, Preclinical/Translational, and High-Risk/High-Impact (new this year) grant programs. 

The LOI submission deadline is Wednesday, November 15 at 5 pm EST. Invitations to submit a full proposal will be sent to applicants in January 2024, and grants will be awarded in Summer 2024. 

See more information about these grants and apply